HCL Tablets - Search News

FDA Recalls Half a Million Bottles of Blood Pressure Drug

Blood Pressure Medicine Recalled After Drug Makers Say It Was Tainted with Cancer-Causing Chemical

Drug makers have recalled more than 500,000 bottles of a blood pressure medication over concerns it may include a cancer-causing chemical.

· 3d

FDA recalls blood pressure medicine over cancerous chemical

· 1d · on MSN

580,000 bottles of a blood pressure drug recalled over cancer risk, FDA says

· 1d

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-cau...

· 1d

Blood pressure medication recalled over potential carcinogen: What to know

· 6h

FDA recalls blood pressure medication over cancer risk, impacting half a million bottles

· 1d

Teva Pharmaceuticals recalls blood pressure medication. How to check your medication

The recall involves more than 580,000 prazosin hydrochloride capsules distributed by Teva Pharmaceuticals.

· 1d

Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride

· 1d

FDA warns this blood pressure medication may have cancer-causing chemicals. See recall list

Monthly Prescribing Reference

Bupropion Hcl Tablets

Swallow whole. Avoid bedtime dosing. ≥18yrs: initially 100mg twice daily for at least 3 days; if tolerated, increase to 100mg 3 times daily at least 6hrs apart; max increase 100mg/day per 3-day period. May increase after several weeks to max 450mg/day in ...

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated with minimal effects on weight or blood pressure and discontinuation rate of 19% vs.